We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
28 August 2019
Advanced therapeutic products have been the topic of much debate recently. First, on 21 June 2019 Bill C-97 received royal assent. Bill C-97 includes amendments to the Food and Drugs Act, including a new framework for advanced therapeutic products and will come into force on a day to be fixed. Second, on 18 July 2019 Health Canada opened a consultation to seek feedback on what it should consider when developing new clinical trial regulations as well as implementing the pathway for advanced therapeutic products. The consultation will close on 30 August 2019.
For further information on this topic please contact Katie Lee at Smart & Biggar/Fetherstonhaugh by telephone (+1 416 593 5514) or email (firstname.lastname@example.org). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.